Use of SSRIs With Oral Anticoagulants and Risk of Major Bleeding
April 12, 2024
A recent population-based, nested case-control study assessed wheth...
Read More
Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia
April 2, 2024
In a recent study examined the efficacy of various treatments for a...
Read More
Liraglutide for Weight Loss in Stable Bipolar Disorder
February 2, 2024
An all-too-common comorbidity for those suffering with bipolar diso...
Read More
ADHD Medications and Long-Term Risk of Cardiovascular Diseases: New Data
December 4, 2023
This recently published case-control study explores the potential c...
Read More
Sexual Dysfunction in Schizophrenia
October 9, 2023
Schizophrenia has high prevalence rates of sexual dysfunction; howe...
Read More
Antipsychotic Polypharmacy Increases Risk of Hypertension, Study Suggests
September 21, 2023
In some cases, treating schizophrenia is especially difficult and m...
Read More
Risk of Akathisia Differs Among Antipsychotics and Dosage
September 16, 2023
Akathisia is a movement disorder that consists of increased motor a...
Read More
Role of the Gut-Brain Axis and Psychiatric Diseases
May 15, 2023
Numerous studies have found a profound association between gastroin...
Read More
Tardive Dyskinesia Awareness Week
May 3, 2023
Every year, we recognize the first full week of May as Tardive Dysk...
Read More
Potential Add-On Therapy To An Antipsychotic For Treatment-Resistant Schizophrenia
January 25, 2023
Interim results from an exploratory clinical trial demonstrate sust...
Read More
Risk of Cardiovascular Diseases Associated With Medications Used in ADHD
December 19, 2022
In a recent cohort study, the relationship benzodiazepines versus a...
Read More
FDA Resource for Dietary Supplements
July 11, 2022
The U.S. Food and Drug Administration has released a resource for c...
Read More